NDAORALTABLET
Approved
Sep 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
6
Clinical Trials (5)
Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528
Started Sep 2010
295 enrolled
Parkinson Disease
REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study
Started Jun 2007
123 enrolled
Parkinson DiseaseParkinson's Disease
Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo
Started Jun 2006
9 enrolled
Sexual Dysfunction
REQUIP RLS Post Marketing Surveillance
Started Apr 2006
755 enrolled
Restless Legs Syndrome
Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease
Started Nov 2005
20 enrolled
Parkinson's Disease